Cure U.S. vs. China Biotech Competitiveness Scorecard (IMAGE)
Caption
The U.S.-China Biotech Competitiveness Scorecard: Where Each Country Leads, across 35 metrics in six dimensions of end-to-end innovation. Visit the Cure Innovation Index U.S.-China Biotech Competitiveness Scorecard report for the complete findings and methodology from five Cure Innovation Index analyses:
- a survey of senior U.S. industry and academic leaders fielded in June 2026
- three bibliometric studies of the top 10 biomedical research institutions in each country
- a clinical trial infrastructure and commercial embeddedness analysis across U.S. and Chinese institutions.
Credit
Cure Innovation Index
Usage Restrictions
Credit must be given to the creator.
License
CC BY